Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression
- 15 December 2003
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 211 (1-2), 15-19
- https://doi.org/10.1016/j.mce.2003.09.006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Requirement of Bmpr1a for Müllerian duct regression during male sexual developmentNature Genetics, 2002
- Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 ExpressionMolecular Endocrinology, 2001
- The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance SignalingMolecular Endocrinology, 2001
- Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Müllerian Hormone and Its Type II ReceptorJournal of Biological Chemistry, 2000
- Targeted Mutagenesis of the Endogenous Mouse Mis Gene PromoterCell, 1999
- Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig CellsEndocrinology, 1999
- Sequence, Genomic Organization, and Chromosomal Location of the Mouse Müllerian-Inhibiting Substance Type II Receptor GeneBiochemical and Biophysical Research Communications, 1997
- Developmental expression of a candidate mullerian inhibiting substance type II receptorEndocrinology, 1996
- Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.Genes & Development, 1995
- Structure and Chromosomal Localization of the Human Anti-Müllerian Hormone Type II Receptor GeneBiochemical and Biophysical Research Communications, 1995